BioMedNewsBreaks – Why VistaGen Therapeutics (NASDAQ: VTGN) Is ‘One to Watch’
Oct 7, 2020
VistaGen Therapeutics (NASDAQ: VTGN) is a biopharmaceutical company committed to developing and commercializing a new generation of medications that go beyond the standard of care for anxiety, depression and other central nervous system (“CNS”) disorders. Based out of South San Francisco, California, the “Birthplace of Biotechnology,” VistaGen is headquartered among the largest cluster of biotechnology companies in the world. A recent article discussing the company reads, “VistaGen currently has three innovative CNS drug candidates in its pipeline: PH94B, PH10 and AV-101. With a differentiated mechanism of action and an exceptional safety profile in all clinical studies to date, each of VistaGen’s three drug candidates offers significant commercialization potential in multiple large CNS markets.”
To view the full article, visit https://ibn.fm/N9ZB3
About VistaGen Therapeutics
VistaGen is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen’s three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date and therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com.
NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Chancellor rejects calls to raise Capital Gains Tax in Budget
Influential Labour figures had been pushing for equalising CGT and income tax, but critics have said this could drive wealthy people out of Britain.
Knicks Ticket Prices Are Soaring After Last Season’s Championship
Knicks tickets have never been cheap, but prices for the first game alone are soaring after last season’s championship — more than a trip to Paris.
How Do Airports Prepare for a Plane Crash? Go Inside JFK’s Disaster Drill.
U.S. airports are required to hold a full-scale disaster drill every three years. Go inside a simulated plane crash at Kennedy Airport last weekend.
Burnham vows end to 'rip-off parking charges' under new rules
The changes come after concerns that penalties issued by private providers are too harsh and leave motorists unfairly punished.
Revolut outage hits 'multiple services' as thousands of users report app issues
Some users of the British neobank reported being unable to make some payments or access funds in its app on Tuesday.
What is the Budget and what could be in it?
Chancellor John Healey will set out his plans for UK taxes on 28 October.
Food aid charity under pressure from fuel costs
FareShare South West says fuel costs are putting immense pressure on work helping thousands in need.
How is the US economy really doing under President Trump?
Ahead of the midterms Trump has boasted about the performance of the US economy. BBC Verify looks at inflation, jobs and economic growth in the country.
Graphics: China's economy picks up steam in Q3
Graphics: China's economy picks up steam in Q3
The VW Bus, Now Electrified, Keeps on Truckin’
A restored version of Volkswagen’s Flower Power-era Microbus, kitted out by Kindred Motorworks, is aiming for the affluent, while VW’s own E.V. is slow to get moving, much like its forebear.
‘A Ticking Time Bomb’: An Economic Crisis Looms in Indonesia
Once a model of economic stability, Indonesia now faces growing hardship at home as President Prabowo Subianto’s policies shake investor confidence.
Black Unemployment Hints at a Job Market in Worse Shape Than It Seems
The Black unemployment rate climbed a percentage point to 7 percent in September, almost double the rate for white workers.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.